Hct 1 A Pharma (Hydrochlorothiazide)

Hydrochlorothiazide, the active component of Hct 1 A Pharma, is indicated for several cardiovascular and renal conditions.

• Treatment of hypertension, either alone or in combination with other antihypertensive agents.
• Management of edema associated with congestive heart failure, liver cirrhosis, or renal disease.
• Reduction of fluid accumulation in patients with nephrotic syndrome.
• Adjunct therapy to prevent calcium‑containing kidney stones.
• Short‑term control of blood pressure before definitive therapy.

Like other thiazide diuretics, hydrochlorothiazide may cause a range of adverse effects, most of which are mild and reversible.

Common

• Increased frequency of urination and mild fluid loss.
• Dizziness or light‑headedness, especially when standing quickly.
• Low potassium levels (hypokalemia) leading to muscle weakness or cramps.
• Elevated blood sugar levels in susceptible individuals.
• Sensitivity to sunlight causing skin rash.

Serious

• Severe dehydration or electrolyte imbalance such as hyponatremia.
• Acute gout attacks due to elevated uric acid.
• Pancreatitis, though rare.
• Severe allergic reactions including Stevens‑Johnson syndrome.
• Significant drop in blood pressure (hypotension).

Before initiating therapy with Hct 1 A Pharma, certain precautions should be considered to minimize risks.

• Assess renal and hepatic function, as impaired clearance can increase drug exposure.
• Monitor electrolyte levels, especially potassium and sodium, during treatment.
• Use cautiously in patients with diabetes, as thiazides may affect glucose control.
• Evaluate history of gout, since the medication can raise uric acid concentrations.
• Consider potential pregnancy or lactation status; safety data are limited.
• Review concurrent use of other diuretics or antihypertensives to avoid excessive volume depletion.

Hydrochlorothiazide can interact with several medicines, altering its effectiveness or increasing the risk of adverse events.

Avoid

• Non‑steroidal anti‑inflammatory drugs (NSAIDs), which may reduce diuretic efficacy.
• Lithium, as thiazides can increase lithium concentrations and toxicity.
• Digoxin, due to enhanced risk of arrhythmias from electrolyte shifts.
• Corticosteroids, which may potentiate fluid and electrolyte loss.
• Other potent diuretics that can cause excessive dehydration.

Use with caution

• ACE inhibitors or angiotensin‑II receptor blockers, which together may cause marked drops in blood pressure.
• Antidiabetic agents, because thiazides can raise blood glucose levels.
• Beta‑blockers, requiring monitoring for additive hypotensive effects.
• Antihistamines, which may increase dizziness.